3//SEC Filing
SMITH ALAN E 3
Accession 0000899243-21-030054
CIK 0001841387other
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 9:24 PM ET
Size
7.1 KB
Accession
0000899243-21-030054
Insider Transaction Report
Form 3
SMITH ALAN E
Director
Holdings
- 32,548
Common Stock
Stock Option (Right to Buy)
Exercise: $1.55Exp: 2030-12-14→ Common Stock (16,274 underlying)Stock Option (Right to Buy)
Exercise: $1.46Exp: 2028-08-17→ Common Stock (4,068 underlying)Stock Option (Right to Buy)
Exercise: $6.64Exp: 2031-06-23→ Common Stock (16,274 underlying)
Footnotes (2)
- [F1]25% of this option vested and became exercisable on May 28, 2019, with an additional 25% vesting on January 1, 2020 and the remainder vesting in 36 substantially equal monthly installments thereafter.
- [F2]This option is fully vested and exercisable as of the date hereof.
Documents
Issuer
Candel Therapeutics, Inc.
CIK 0001841387
Entity typeother
IncorporatedMA
Related Parties
1- filerCIK 0001021037
Filing Metadata
- Form type
- 3
- Filed
- Jul 25, 8:00 PM ET
- Accepted
- Jul 26, 9:24 PM ET
- Size
- 7.1 KB